Global Pets Anti-infective Drugs Market Growth 2021-2026

Publisher Name :
Date: 26-Nov-2021
No. of pages: 101

According to this latest study, the 2021 growth of Pets Anti-infective Drugs will have significant change from previous year. By the most conservative estimates of global Pets Anti-infective Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Pets Anti-infective Drugs market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Pets Anti-infective Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by administration method: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

- External Use

- Internal Use

- Injection

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

- Dog

- Cat

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

- Zoetis

- Merck

- Elanco

- Virbac

- Dechra Veterinary Products

- Ceva Santé Animale

- Vetoquinol

- Nanjing Jindun Animal

- Wuhan Chopperlvya

- Bimeda Animal Health

- Ouro Fino Saude

- Norbrook

Global Pets Anti-infective Drugs Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pets Anti-infective Drugs Consumption 2016-2026
2.1.2 Pets Anti-infective Drugs Consumption CAGR by Region
2.2 Pets Anti-infective Drugs Segment by Administration Method
2.2.1 External Use
2.2.2 Internal Use
2.2.3 Injection
2.3 Pets Anti-infective Drugs Sales by Administration Method
2.3.1 Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2016-2021)
2.3.2 Global Pets Anti-infective Drugs Revenue and Market Share by Administration Method (2016-2021)
2.3.3 Global Pets Anti-infective Drugs Sale Price by Administration Method (2016-2021)
2.4 Pets Anti-infective Drugs Segment by Application
2.4.1 Dog
2.4.2 Cat
2.4.3 Others
2.5 Pets Anti-infective Drugs Sales by Application
2.5.1 Global Pets Anti-infective Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Pets Anti-infective Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Pets Anti-infective Drugs Sale Price by Application (2016-2021)

3 Global Pets Anti-infective Drugs by Company
3.1 Global Pets Anti-infective Drugs Sales Market Share by Company
3.1.1 Global Pets Anti-infective Drugs Sales by Company (2019-2021)
3.1.2 Global Pets Anti-infective Drugs Sales Market Share by Company (2019-2021)
3.2 Global Pets Anti-infective Drugs Revenue Market Share by Company
3.2.1 Global Pets Anti-infective Drugs Revenue by Company (2019-2021)
3.2.2 Global Pets Anti-infective Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Pets Anti-infective Drugs Sale Price by Company
3.4 Global Manufacturers Pets Anti-infective Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pets Anti-infective Drugs Product Location Distribution
3.4.2 Players Pets Anti-infective Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Pets Anti-infective Drugs by Region
4.1 Global Pets Anti-infective Drugs by Region
4.1.1 Global Pets Anti-infective Drugs Sales by Region
4.1.2 Global Pets Anti-infective Drugs Revenue by Region
4.2 Americas Pets Anti-infective Drugs Sales Growth
4.3 APAC Pets Anti-infective Drugs Sales Growth
4.4 Europe Pets Anti-infective Drugs Sales Growth
4.5 Middle East & Africa Pets Anti-infective Drugs Sales Growth

5 Americas
5.1 Americas Pets Anti-infective Drugs Sales by Country
5.1.1 Americas Pets Anti-infective Drugs Sales by Country (2016-2021)
5.1.2 Americas Pets Anti-infective Drugs Revenue by Country (2016-2021)
5.2 Americas Pets Anti-infective Drugs Sales by Administration Method
5.3 Americas Pets Anti-infective Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Pets Anti-infective Drugs Sales by Region
6.1.1 APAC Pets Anti-infective Drugs Sales by Region (2016-2021)
6.1.2 APAC Pets Anti-infective Drugs Revenue by Region (2016-2021)
6.2 APAC Pets Anti-infective Drugs Sales by Administration Method
6.3 APAC Pets Anti-infective Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Pets Anti-infective Drugs by Country
7.1.1 Europe Pets Anti-infective Drugs Sales by Country (2016-2021)
7.1.2 Europe Pets Anti-infective Drugs Revenue by Country (2016-2021)
7.2 Europe Pets Anti-infective Drugs Sales by Administration Method
7.3 Europe Pets Anti-infective Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Pets Anti-infective Drugs by Country
8.1.1 Middle East & Africa Pets Anti-infective Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Pets Anti-infective Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Pets Anti-infective Drugs Sales by Administration Method
8.3 Middle East & Africa Pets Anti-infective Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pets Anti-infective Drugs Distributors
10.3 Pets Anti-infective Drugs Customer

11 Global Pets Anti-infective Drugs Market Forecast
11.1 Global Pets Anti-infective Drugs Forecast by Region
11.1.1 Global Pets Anti-infective Drugs Forecast by Regions (2021-2026)
11.2.2 Global Pets Anti-infective Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Pets Anti-infective Drugs Forecast by Administration Method
11.7 Global Pets Anti-infective Drugs Forecast by Application

12 Key Players Analysis
12.1 Zoetis
12.1.1 Zoetis Company Information
12.1.2 Zoetis Pets Anti-infective Drugs Product Offered
12.1.3 Zoetis Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Zoetis Main Business Overview
12.1.5 Zoetis Latest Developments
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Pets Anti-infective Drugs Product Offered
12.2.3 Merck Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merck Main Business Overview
12.2.5 Merck Latest Developments
12.3 Elanco
12.3.1 Elanco Company Information
12.3.2 Elanco Pets Anti-infective Drugs Product Offered
12.3.3 Elanco Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Elanco Main Business Overview
12.3.5 Elanco Latest Developments
12.4 Virbac
12.4.1 Virbac Company Information
12.4.2 Virbac Pets Anti-infective Drugs Product Offered
12.4.3 Virbac Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Virbac Main Business Overview
12.4.5 Virbac Latest Developments
12.5 Dechra Veterinary Products
12.5.1 Dechra Veterinary Products Company Information
12.5.2 Dechra Veterinary Products Pets Anti-infective Drugs Product Offered
12.5.3 Dechra Veterinary Products Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Dechra Veterinary Products Main Business Overview
12.5.5 Dechra Veterinary Products Latest Developments
12.6 Ceva Santé Animale
12.6.1 Ceva Santé Animale Company Information
12.6.2 Ceva Santé Animale Pets Anti-infective Drugs Product Offered
12.6.3 Ceva Santé Animale Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Ceva Santé Animale Main Business Overview
12.6.5 Ceva Santé Animale Latest Developments
12.7 Vetoquinol
12.7.1 Vetoquinol Company Information
12.7.2 Vetoquinol Pets Anti-infective Drugs Product Offered
12.7.3 Vetoquinol Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Vetoquinol Main Business Overview
12.7.5 Vetoquinol Latest Developments
12.8 Nanjing Jindun Animal
12.8.1 Nanjing Jindun Animal Company Information
12.8.2 Nanjing Jindun Animal Pets Anti-infective Drugs Product Offered
12.8.3 Nanjing Jindun Animal Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Nanjing Jindun Animal Main Business Overview
12.8.5 Nanjing Jindun Animal Latest Developments
12.9 Wuhan Chopperlvya
12.9.1 Wuhan Chopperlvya Company Information
12.9.2 Wuhan Chopperlvya Pets Anti-infective Drugs Product Offered
12.9.3 Wuhan Chopperlvya Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Wuhan Chopperlvya Main Business Overview
12.9.5 Wuhan Chopperlvya Latest Developments
12.10 Bimeda Animal Health
12.10.1 Bimeda Animal Health Company Information
12.10.2 Bimeda Animal Health Pets Anti-infective Drugs Product Offered
12.10.3 Bimeda Animal Health Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Bimeda Animal Health Main Business Overview
12.10.5 Bimeda Animal Health Latest Developments
12.11 Ouro Fino Saude
12.11.1 Ouro Fino Saude Company Information
12.11.2 Ouro Fino Saude Pets Anti-infective Drugs Product Offered
12.11.3 Ouro Fino Saude Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Ouro Fino Saude Main Business Overview
12.11.5 Ouro Fino Saude Latest Developments
12.12 Norbrook
12.12.1 Norbrook Company Information
12.12.2 Norbrook Pets Anti-infective Drugs Product Offered
12.12.3 Norbrook Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Norbrook Main Business Overview
12.12.5 Norbrook Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Pets Anti-infective Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of External Use
Table 3. Major Players of Internal Use
Table 4. Major Players of Injection
Table 5. Global Pets Anti-infective Drugs Sales by Administration Method (2016-2021) & (K Units)
Table 6. Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2016-2021)
Table 7. Global Pets Anti-infective Drugs Revenue by Administration Method (2016-2021) & ($ million)
Table 8. Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2016-2021)
Table 9. Global Pets Anti-infective Drugs Sale Price by Administration Method (2016-2021)
Table 10. Global Pets Anti-infective Drugs Sales by Application (2016-2021) & (K Units)
Table 11. Global Pets Anti-infective Drugs Sales Market Share by Application (2016-2021)
Table 12. Global Pets Anti-infective Drugs Value by Application (2016-2021)
Table 13. Global Pets Anti-infective Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Pets Anti-infective Drugs Sale Price by Application (2016-2021)
Table 15. Global Pets Anti-infective Drugs Sales by Company (2019-2021) & (K Units)
Table 16. Global Pets Anti-infective Drugs Sales Market Share by Company (2019-2021)
Table 17. Global Pets Anti-infective Drugs Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Pets Anti-infective Drugs Revenue Market Share by Company (2019-2021)
Table 19. Global Pets Anti-infective Drugs Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Pets Anti-infective Drugs Producing Area Distribution and Sales Area
Table 21. Players Pets Anti-infective Drugs Products Offered
Table 22. Pets Anti-infective Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pets Anti-infective Drugs Sales by Region (2016-2021) (K Units)
Table 26. Global Pets Anti-infective Drugs Sales Market Share by Region (2016-2021)
Table 27. Global Pets Anti-infective Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Pets Anti-infective Drugs Revenue Market Share by Region (2016-2021)
Table 29. Americas Pets Anti-infective Drugs Sales by Country (2016-2021) & (K Units)
Table 30. Americas Pets Anti-infective Drugs Sales Market Share by Country (2016-2021)
Table 31. Americas Pets Anti-infective Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Pets Anti-infective Drugs Revenue Market Share by Country (2016-2021)
Table 33. Americas Pets Anti-infective Drugs Sales by Type (2016-2021) & (K Units)
Table 34. Americas Pets Anti-infective Drugs Sales Market Share by Administration Method (2016-2021)
Table 35. Americas Pets Anti-infective Drugs Sales by Application (2016-2021) & (K Units)
Table 36. Americas Pets Anti-infective Drugs Sales Market Share by Application (2016-2021)
Table 37. APAC Pets Anti-infective Drugs Sales by Region (2016-2021) & (K Units)
Table 38. APAC Pets Anti-infective Drugs Sales Market Share by Region (2016-2021)
Table 39. APAC Pets Anti-infective Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Pets Anti-infective Drugs Revenue Market Share by Region (2016-2021)
Table 41. APAC Pets Anti-infective Drugs Sales by Administration Method (2016-2021) & (K Units)
Table 42. APAC Pets Anti-infective Drugs Sales Market Share by Administration Method (2016-2021)
Table 43. APAC Pets Anti-infective Drugs Sales by Application (2016-2021) & (K Units)
Table 44. APAC Pets Anti-infective Drugs Sales Market Share by Application (2016-2021)
Table 45. Europe Pets Anti-infective Drugs Sales by Country (2016-2021) & (K Units)
Table 46. Europe Pets Anti-infective Drugs Sales Market Share by Country (2016-2021)
Table 47. Europe Pets Anti-infective Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Pets Anti-infective Drugs Revenue Market Share by Country (2016-2021)
Table 49. Europe Pets Anti-infective Drugs Sales by Type (2016-2021) & (K Units)
Table 50. Europe Pets Anti-infective Drugs Sales Market Share by Administration Method (2016-2021)
Table 51. Europe Pets Anti-infective Drugs Sales by Application (2016-2021) & (K Units)
Table 52. Europe Pets Anti-infective Drugs Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Pets Anti-infective Drugs Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Pets Anti-infective Drugs Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Pets Anti-infective Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Pets Anti-infective Drugs Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Pets Anti-infective Drugs Sales by Administration Method (2016-2021) & (K Units)
Table 58. Middle East & Africa Pets Anti-infective Drugs Sales Market Share by Administration Method (2016-2021)
Table 59. Middle East & Africa Pets Anti-infective Drugs Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Pets Anti-infective Drugs Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Pets Anti-infective Drugs
Table 62. Key Application and Potential Industries of Pets Anti-infective Drugs
Table 63. Key Challenges of Pets Anti-infective Drugs
Table 64. Key Trends of Pets Anti-infective Drugs
Table 65. Pets Anti-infective Drugs Distributors List
Table 66. Pets Anti-infective Drugs Customer List
Table 67. Global Pets Anti-infective Drugs Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Pets Anti-infective Drugs Consumption Market Forecast by Region
Table 69. Global Pets Anti-infective Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Pets Anti-infective Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Pets Anti-infective Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Pets Anti-infective Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Pets Anti-infective Drugs Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Pets Anti-infective Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Pets Anti-infective Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Pets Anti-infective Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Pets Anti-infective Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Pets Anti-infective Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Pets Anti-infective Drugs Sales Forecast by Administration Method (2021-2026) & (K Units)
Table 80. Global Pets Anti-infective Drugs Sales Market Share Forecast by Administration Method (2021-2026)
Table 81. Global Pets Anti-infective Drugs Revenue Forecast by Administration Method (2021-2026) & ($ Millions)
Table 82. Global Pets Anti-infective Drugs Revenue Market Share Forecast by Administration Method (2021-2026)
Table 83. Global Pets Anti-infective Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Pets Anti-infective Drugs Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Pets Anti-infective Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Pets Anti-infective Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 87. Zoetis Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Zoetis Pets Anti-infective Drugs Product Offered
Table 89. Zoetis Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. Zoetis Main Business
Table 91. Zoetis Latest Developments
Table 92. Merck Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Pets Anti-infective Drugs Product Offered
Table 94. Merck Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. Elanco Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Elanco Pets Anti-infective Drugs Product Offered
Table 99. Elanco Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. Elanco Main Business
Table 101. Elanco Latest Developments
Table 102. Virbac Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Virbac Pets Anti-infective Drugs Product Offered
Table 104. Virbac Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Virbac Main Business
Table 106. Virbac Latest Developments
Table 107. Dechra Veterinary Products Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Dechra Veterinary Products Pets Anti-infective Drugs Product Offered
Table 109. Dechra Veterinary Products Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Dechra Veterinary Products Main Business
Table 111. Dechra Veterinary Products Latest Developments
Table 112. Ceva Santé Animale Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Ceva Santé Animale Pets Anti-infective Drugs Product Offered
Table 114. Ceva Santé Animale Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. Ceva Santé Animale Main Business
Table 116. Ceva Santé Animale Latest Developments
Table 117. Vetoquinol Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Vetoquinol Pets Anti-infective Drugs Product Offered
Table 119. Vetoquinol Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. Vetoquinol Main Business
Table 121. Vetoquinol Latest Developments
Table 122. Nanjing Jindun Animal Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Nanjing Jindun Animal Pets Anti-infective Drugs Product Offered
Table 124. Nanjing Jindun Animal Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. Nanjing Jindun Animal Main Business
Table 126. Nanjing Jindun Animal Latest Developments
Table 127. Wuhan Chopperlvya Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Wuhan Chopperlvya Pets Anti-infective Drugs Product Offered
Table 129. Wuhan Chopperlvya Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 130. Wuhan Chopperlvya Main Business
Table 131. Wuhan Chopperlvya Latest Developments
Table 132. Bimeda Animal Health Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Bimeda Animal Health Pets Anti-infective Drugs Product Offered
Table 134. Bimeda Animal Health Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 135. Bimeda Animal Health Main Business
Table 136. Bimeda Animal Health Latest Developments
Table 137. Ouro Fino Saude Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Ouro Fino Saude Pets Anti-infective Drugs Product Offered
Table 139. Ouro Fino Saude Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 140. Ouro Fino Saude Main Business
Table 141. Ouro Fino Saude Latest Developments
Table 142. Norbrook Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Norbrook Pets Anti-infective Drugs Product Offered
Table 144. Norbrook Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 145. Norbrook Main Business
Table 146. Norbrook Latest Developments
List of Figures
Figure 1. Picture of Pets Anti-infective Drugs
Figure 2. Pets Anti-infective Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pets Anti-infective Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Pets Anti-infective Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Pets Anti-infective Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of External Use
Figure 10. Product Picture of Internal Use
Figure 11. Product Picture of Injection
Figure 12. Global Pets Anti-infective Drugs Sales Market Share by Administration Method in 2020
Figure 13. Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2016-2021)
Figure 14. Pets Anti-infective Drugs Consumed in Dog
Figure 15. Global Pets Anti-infective Drugs Market: Dog (2016-2021) & (K Units)
Figure 16. Pets Anti-infective Drugs Consumed in Cat
Figure 17. Global Pets Anti-infective Drugs Market: Cat (2016-2021) & (K Units)
Figure 18. Pets Anti-infective Drugs Consumed in Others
Figure 19. Global Pets Anti-infective Drugs Market: Others (2016-2021) & (K Units)
Figure 20. Global Pets Anti-infective Drugs Sales Market Share by Application (2016-2021)
Figure 21. Global Pets Anti-infective Drugs Revenue Market Share by Application in 2020
Figure 22. Pets Anti-infective Drugs Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Pets Anti-infective Drugs Revenue Market Share by Company in 2020
Figure 24. Global Pets Anti-infective Drugs Sales Market Share by Regions (2016-2021)
Figure 25. Global Pets Anti-infective Drugs Revenue Market Share by Region in 2020
Figure 26. Americas Pets Anti-infective Drugs Sales 2016-2021 (K Units)
Figure 27. Americas Pets Anti-infective Drugs Revenue 2016-2021 ($ Millions)
Figure 28. APAC Pets Anti-infective Drugs Sales 2016-2021 (K Units)
Figure 29. APAC Pets Anti-infective Drugs Revenue 2016-2021 ($ Millions)
Figure 30. Europe Pets Anti-infective Drugs Sales 2016-2021 (K Units)
Figure 31. Europe Pets Anti-infective Drugs Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Pets Anti-infective Drugs Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Pets Anti-infective Drugs Revenue 2016-2021 ($ Millions)
Figure 34. Americas Pets Anti-infective Drugs Sales Market Share by Country in 2020
Figure 35. Americas Pets Anti-infective Drugs Revenue Market Share by Country in 2020
Figure 36. Americas Pets Anti-infective Drugs Sales Market Share by Administration Method in 2020
Figure 37. Americas Pets Anti-infective Drugs Sales Market Share by Application in 2020
Figure 38. United States Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Pets Anti-infective Drugs Sales Market Share by Region in 2020
Figure 43. APAC Pets Anti-infective Drugs Revenue Market Share by Regions in 2020
Figure 44. APAC Pets Anti-infective Drugs Sales Market Share by Administration Method in 2020
Figure 45. APAC Pets Anti-infective Drugs Sales Market Share by Application in 2020
Figure 46. China Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Pets Anti-infective Drugs Sales Market Share by Country in 2020
Figure 53. Europe Pets Anti-infective Drugs Revenue Market Share by Country in 2020
Figure 54. Europe Pets Anti-infective Drugs Sales Market Share by Administration Method in 2020
Figure 55. Europe Pets Anti-infective Drugs Sales Market Share by Application in 2020
Figure 56. Germany Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Pets Anti-infective Drugs Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Pets Anti-infective Drugs Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Pets Anti-infective Drugs Sales Market Share by Administration Method in 2020
Figure 64. Middle East & Africa Pets Anti-infective Drugs Sales Market Share by Application in 2020
Figure 65. Egypt Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs